Bayer significantly improves earnings
- Details
- Category: Bayer

AstraZeneca further sharpens focus through agreement with Genzyme for rare disease medicine Caprelsa
- Details
- Category: AstraZeneca

European Commission approves Amgen's new cholesterol-lowering medication Repatha™ (evolocumab)
- Details
- Category: Amgen

AstraZeneca completes agreement with Tillotts Pharma for Entocort
- Details
- Category: AstraZeneca

Novartis malaria treatment Coartem® 80/480mg receives WHO prequalification, enabling greater access for patients
- Details
- Category: Novartis

IRESSA approved by US FDA for first-line treatment of patients with advanced EGFR mutation-positive non-small cell lung cancer
- Details
- Category: AstraZeneca

Pfizer's Centers for Therapeutic Innovation and Jeffrey Modell Foundation announce collaboration
- Details
- Category: Pfizer

More Pharma News ...
- AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma
- Novartis Pharmaceuticals launches the first app for visually impaired people for use with the Apple Watch and other smart watches
- Novartis deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc.
- Pfizer enters into agreement to acquire Nimenrix and Mencevax from GlaxoSmithKline
- Novartis highlights strong innovation momentum at its second Meet Novartis Management investor day
- Roche employees unite to raise funds for children in need
- Bayer to divest Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for EUR 1,022 million